The pre-programmed device delivers 30mg of furosemide over the first hour followed by 12.5mg per hour for the subsequent 4 hours. The Food and Drug Administration (FDA) has approved Lasix ® ONYU ...
The study covered in this summary was published on ResearchSquare.com as a preprint and has not yet been peer reviewed. The influence of furosemide on prognosis after cardiac surgery is not fully ...
Health and Me on MSN
NHS warns furosemide users about dehydration risk: here’s why
NHS warns furosemide users about dehydration risks, listing who should speak to a doctor, medicines to avoid, and how the ...
The US Food and Drug Administration (FDA) has approved a furosemide preparation (Furoscix, scPharmaceuticals) intended for subcutaneous self-administration by outpatients with chronic heart failure ...
Subcutaneous (SC) furosemide, a novel way to deliver diuretic therapy, may improve symptoms and functional capacity in patients with heart failure (HF) and worsening congestion, according to results ...
In an observational study, furosemide doses of 250 to 500 mg and spironolactone doses of 50 to 100 mg were independently associated with approximately 14% and 20% increased odds of hyponatremia, ...
Outcomes from the loop diuretics were compared in this analysis, with study participants from the TRANSFORM-HF trial matched 1:1, all having been hospitalized for either do novo disease or worsening ...
MADRID, Spain—A novel patch-pump capable of delivering subcutaneous furosemide over a 5-hour period results in similar bioavailability and efficacy as an intravenous infusion and is well tolerated by ...
FDA approves FUROSCIX® for use in pediatric patients weighing 43kg or aboveUSPTO issues five patents for FUROSCIX ReadyFlow™ AutoinjectorWESTLAKE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback